• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism.

作者信息

Chatzikyriakidou A, Georgiou I, Voulgari P V, Venetsanopoulou A I, Drosos A A

出版信息

Rheumatology (Oxford). 2007 Jun;46(6):1034-5. doi: 10.1093/rheumatology/kem041. Epub 2007 Apr 4.

DOI:10.1093/rheumatology/kem041
PMID:17409133
Abstract
摘要

相似文献

1
Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism.肿瘤坏死因子-α与肿瘤坏死因子受体的联合基因型可预测类风湿关节炎患者对抗肿瘤坏死因子-α治疗的反应，并解释基于单一多态性的研究争议。
Rheumatology (Oxford). 2007 Jun;46(6):1034-5. doi: 10.1093/rheumatology/kem041. Epub 2007 Apr 4.
2
Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis.肿瘤坏死因子-α（TNF-α）水平以及-308 TNF-α启动子多态性对类风湿关节炎患者英夫利昔单抗反应性的影响
Scand J Rheumatol. 2004;33(4):228-32. doi: 10.1080/03009740410005863.
3
Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.Fcγ受体IIA和IIIA变体对美国风湿病学会和欧洲抗风湿病联盟制定的类风湿关节炎抗肿瘤坏死因子α治疗反应的影响
Ann Rheum Dis. 2009 Oct;68(10):1547-52. doi: 10.1136/ard.2008.096982. Epub 2008 Oct 17.
4
Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis.肿瘤坏死因子α基因-308位的多态性影响类风湿关节炎患者英夫利昔单抗治疗的疗效。
Arthritis Rheum. 2003 Jul;48(7):1849-52. doi: 10.1002/art.11168.
5
Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.利妥昔单抗与抗肿瘤坏死因子-α阻滞剂联合治疗成功治愈严重难治性类风湿关节炎。
J Rheumatol. 2009 Sep;36(9):2125-6. doi: 10.3899/jrheum.090160.
6
Tumor necrosis factor alpha haplotypes versus tumor necrosis factor alpha -308 G/A polymorphism in the prediction of infliximab treatment efficacy in rheumatoid arthritis.肿瘤坏死因子α单倍型与肿瘤坏死因子α -308 G/A多态性在预测类风湿关节炎英夫利昔单抗治疗疗效中的比较
Arthritis Rheum. 2004 Dec;50(12):4075-6; author reply 4076-7. doi: 10.1002/art.20801.
7
Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.抗肿瘤坏死因子α疗法可调节重度类风湿关节炎患者的胃饥饿素。
Ann Rheum Dis. 2008 Nov;67(11):1644-6. doi: 10.1136/ard.2008.088773.
8
Associations between tumor necrosis factor-alpha (TNF-alpha) -308 and -238 G/A polymorphisms and shared epitope status and responsiveness to TNF-alpha blockers in rheumatoid arthritis: a metaanalysis update.肿瘤坏死因子-α（TNF-α）-308 和 -238 G/A 多态性与共享表位状态及对 TNF-α 阻滞剂反应性在类风湿关节炎中的关系：荟萃分析更新。
J Rheumatol. 2010 Apr;37(4):740-6. doi: 10.3899/jrheum.090707. Epub 2010 Mar 1.
9
Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.B细胞清除疗法对肿瘤坏死因子α拮抗剂治疗无效的类风湿关节炎患者的疗效：一项开放标签观察性研究。
Ann Rheum Dis. 2006 Sep;65(9):1255-7. doi: 10.1136/ard.2005.051169. Epub 2006 Mar 15.
10
Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.抗肿瘤坏死因子治疗：以色列北部单一中心的6年经验及卫生政策对结果的可能影响。
Isr Med Assoc J. 2008 Apr;10(4):277-81.

引用本文的文献

1
The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.遗传因素与生物制剂治疗银屑病、银屑病关节炎、类风湿关节炎和炎症性肠病患者反应的相关性：系统评价和荟萃分析。
Int J Mol Sci. 2024 May 26;25(11):5793. doi: 10.3390/ijms25115793.
2
Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions -308G/A, -857C/T, and -863C/A with etanercept response in Iraqi rheumatoid arthritis patients.伊拉克类风湿关节炎患者中肿瘤坏死因子-α启动子区域-308G/A、-857C/T和-863C/A位点基因多态性与依那西普反应的相关性
Arch Rheumatol. 2022 Mar 3;37(4):613-625. doi: 10.46497/ArchRheumatol.2022.9272. eCollection 2022 Dec.
3
Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis.用于治疗类风湿关节炎的单克隆抗体的药物基因组学
J Pers Med. 2022 Jul 31;12(8):1265. doi: 10.3390/jpm12081265.
4
Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis.参与类风湿关节炎生物制剂反应的多态性。
Biomolecules. 2020 Aug 19;10(9):1203. doi: 10.3390/biom10091203.
5
Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis.组学在预测类风湿关节炎抗 TNF 疗效中的应用。
Clin Rheumatol. 2018 Jan;37(1):13-23. doi: 10.1007/s10067-017-3639-0. Epub 2017 Jun 10.
6
[Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].[类风湿关节炎抗TNF治疗反应的预后生物标志物：我们目前的状况如何？]
Z Rheumatol. 2015 Nov;74(9):812-8. doi: 10.1007/s00393-014-1543-4.
7
Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies.类风湿关节炎的药物遗传学：来自易感基因和现有疗法的潜在靶点。
Pharmgenomics Pers Med. 2010;3:15-31. doi: 10.2147/pgpm.s5012. Epub 2010 Mar 30.
8
TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?青少年特发性关节炎中的肿瘤坏死因子-α基因多态性：有哪些潜在的临床意义？
Int J Rheumatol. 2012;2012:756291. doi: 10.1155/2012/756291. Epub 2012 Oct 21.
9
Association of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorphisms with Ischemic Stroke in a Greek Population.希腊人群中TNF-857C>T、TNFRSF1A36A>G和TNFRSF1B676T>G基因多态性与缺血性中风的关联
Stroke Res Treat. 2011;2011:920584. doi: 10.4061/2011/920584. Epub 2011 May 29.
10
Rheumatoid arthritis: strategies in the management of patients showing an inadequate response to TNFalpha antagonists.类风湿关节炎：对肿瘤坏死因子α拮抗剂反应不足患者的管理策略
Drugs. 2008;68(5):591-606. doi: 10.2165/00003495-200868050-00003.